Navigation Links
Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
Date:4/10/2008

- Full Results to be Presented at European Association for the Study of the

Liver Annual Meeting -

SAN FRANCISCO, April 10 /PRNewswire/ -- Antipodean Pharmaceuticals, Inc. announced today that it has completed its Phase 2 study of its lead compound, MitoQ(R) (mitoquinone) in liver disease. The results of the study will be presented at The European Association for the Study of the Liver (EASL) Annual Meeting, being held April 23 - 27 in Milan, Italy.

The poster, titled "Phase II Study of the Mitochondrial Antioxidant Mitoquinone for Hepatitis C," will be presented April 24, 2008. The 28-day study enrolled 30 patients with Hepatitis C virus (HCV), who had not responded to or were unsuitable for interferon or ribavirin treatment, and measured the effect of MitoQ(R) on liver function tests. Edward Gane, M.D., Associate Professor of Medicine, New Zealand Liver Transplant Unit at Auckland City Hospital, served as principal investigator for the study.

About Hepatitis C Virus (HCV)

HCV, a viral infection of the liver, affects over 170 million people worldwide. Approximately 3 million people in the United States have chronic Hepatitis C infections; however, the true prevalence may be underestimated, since newly infected people usually are asymptomatic for many years. HCV infection is the leading cause of cirrhosis, hepatocellular carcinoma, and liver failure. Current treatment strategies focus on achieving a sustained virologic response, but available therapies have poor side-effect profiles and eradicate HCV in only approximately 50% of individuals. New novel therapies for eradicating the HCV virus and slowing the progression of liver scarring are needed. Evidence shows that HCV can directly alter mitochondrial function, leading to increased reactive oxygen species (free-radical) production that can lead to scarring of the liver and cirrhosis.

About MitoQ(R)

MitoQ(R) is a mitochondria-targeted antioxi
'/>"/>

SOURCE Antipodean Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
2. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
3. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
4. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
5. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
6. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
7. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
8. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
9. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
10. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
11. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...atson Pharmaceuticals, Inc. (NYSE: WPI ), a lead... confirmed that its subsidiary, Watson Laboratorie...lication (ANDA) with the U.S. Food and Drug Admini...eon tablets prior to the expiration of a patent ow...son,s 8mg ramelteon tablet product is a generic ve...
(Date:12/4/2009)...eal Shore and E. David Crawford presented results ...m the additional analysis of secondary end points ...tal study of FIRMAGON® (monthly degarelix for...er patients during the first year of treatment. P...80 mg/month had a recurrence rate of 7.7% during t...
(Date:12/4/2009)...traZeneca (NYSE: AZN ) today announced that the ... once-daily SEROQUEL XR® (quetiapine fumarate...treatment to antidepressants in adults with Major ... medication in its class approved by the FDA to tr...herapy and acute depressive episodes associated wi...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Bird flu leaves the nest adapting to a new host 9699 1Proven Solution for Chinese Drywall is Now Available 55401 1Proven Solution for Chinese Drywall is Now Available 55401 2Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 1Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 2
...stria, July 16 In the clinical phase I trial,AFF0...r patients planned,for this trial. The trial aims ...nnovative Alzheimer,s vaccine (AFFITOPE AD01). In ...t least once and have so far tolerated,the vaccine...accinations,administered at monthly intervals and ...
...Support Phase 2a Clinical Trial at UCSD, NOVATO, ...ptor" or the "Company") (OTC Bulletin Board:,RPTP)... agreement (the,"Agreement") with the University o...e 2a clinical trial to evaluate a delayed-release ...) in adolescents diagnosed with,Non-Alcoholic Stea...
Other Medicine Technology:AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (Heal...th allergies and asthma can have bad reactions to ...l steps to prevent sneezing and wheezing, accordin...mmunology (ACAAI). , Those who are allergic to liv...l plants, but both live and artificial trees can t...
(Date:12/5/2009)...urbines are popping up in the most unusual places,...ng wine to keeping prisoners in jail! , ...ld have thought that your wine, water and vegetabl...f Fort Worth, Texas has announced a new line of tu...Using a technology developed to provide power for ...
(Date:12/4/2009)...ec. 4 Allied World Assurance,Company Holdings, Lt...ani,President and Chief Executive Officer, and Jac...orate Strategy Officer, will be presenting at the ...nce being held at the Goldman,Sachs Conference Cen... ,, About Allied World Assurance Company , ...
(Date:12/4/2009)... Pamela Bowen, Chief Information Officer at Cresce..."Chief Innovation Officer" Appy Award for transfor...omputing. Appy Award recipients are nominated base...he Force.com platform in bringing new levels of cu... service, support or IT organizations. ,, "It is ...
(Date:12/4/2009)...at Johns Hopkins publishing in the December issue ... gene called "Twist" may be the proverbial red fla...drive aggressive, metastatic breast cancer from ot...k suggesting that it is a relatively rare subgroup... cancer, scientists have surmised that this subgro...
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...d women who consumed higher levels of calcium and ...eater volumes of brain lesions, regions of damage/...dementia, depression and stroke. Dr. Payne ..., 153 women) between the ages of 60 and 86 (averag...
...States the gays prefer to find out whether their p... used rather than use protection to prevent// catc...d sex is a sure way of transmitting the virus, whi...t also proved that many of the volunteers were una...
...rving in the rural areas have had enough. Most Doc... long hours of work//. A survey conducted by the A... doctors are sick of the stress because of the sta...e shortage of doctors. The burden then rests on th...
...rican scientists has added a new weapon of defense...study lead by Dr Qiuying Yang, from the University...al of obstetrics and gynecology -BJOG, has linked ...cies recorded by the US National Center for Health...
... the famous Indian epic, a prince donates his yout...e his passions//. Another kind of help is at h... gene that plays a central role in the ageing proc...that are subjected to a calorie-restricted diet -w...
... was vehemently against his wife’s decision to und...is desire too far//. McCarthy, 27, who belonged t...idnapping his wife, Mrs. McCarthy on 9 February fr...fe from the hospital where she was to get a breast...
Other Medicine News:Health News:Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People 2Health News:Unprotected Sex Among the Gays on the Rise 2Health News:Doctors Warned Against Encouraging Elective Caesareans 2Health News:Doctors Warned Against Encouraging Elective Caesareans 3Health News:Gene Responsible for Ageing Process Discovered – and Calorie Restriction Could Hel 2
...atchet design provides fingertip ratchet disengage...e Series I Instrument program offers state-of-the-...ile, while maintaining strength and durability. Lo...n tight joint spaces. Series I instruments are ava...
...atchet design provides fingertip ratchet disengage...e Series I Instrument program offers state-of-the-...ile, while maintaining strength and durability. Lo...n tight joint spaces. Series I instruments are ava...
Graspers Atraumatic
Basket Punches 90 Rotary
Medicine Products: